A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice
Most people find that retatrutide at 4 to 8mg produces appetite suppression equivalent to or greater than tirzepatide at 10 to 15mg
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
(2022) Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation
If youve been scrolling through social media or searching Google for weight loss solutions, youve probably noticed that there are so many options available that it can get overwhelming
Often worth exploring for Adults noticing age-related decline in recovery, sleep, or energy Active people who want a clinician-guided plan instead of self-directed use Patients who want their protocol built on labs, not guesswork People already dialing in nutrition, training, and sleep who want added support Who should avoid CJC-1295 and Ipamorelin